Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
473.00    -2.00 (-0.42%)
Bid:
473.00
Ask:
475.00
Spread: 2.00 (0.423%)
Market Cap: £780.52m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Share Issue and Treasury

9 Dec 2013 07:00

RNS Number : 9688U
Oakley Capital Investments Limited
09 December 2013
Β 

ο»Ώ

09 December 2013

Β 

Β 

Β 

Oakley Capital Investments Limited

Β 

Β 

Share Issue and Treasury

Β 

Β 

On 4 November 2013 Oakley Capital Investments Limited ("the Company") announced that on 7 November 2013 it had sold 584,000 ordinary shares at Β£1.72 per share for settlement from treasury to institutional investors. It also announced on the same date that following this transaction the Company would hold 4,425,950 shares in treasury.

Β 

The Board has discovered that prior to the above transaction, 5,009,950 ordinary shares in OCL previously purchased by the Company were actually cancelled by the Company's registrar and not held in treasury.

Β 

In order to satisfy its obligations under the above ordinary share sale, OCL has issued 584,000 ordinary shares to its counterparty.

Β 

Further, in order to restore the Company's treasury stock to the previously disclosed level, OCL will issue 4,425,950 ordinary shares to Liberum Capital at the prevailing market price and repurchase immediately at the same price.

Β 

Application for admission to AIM has been made in respect of both tranches being 5,009,950 ordinary shares, and admission and trading is expected to occur on or around 13 December 2013.

Β 

Following this transaction the Company will hold 4,425,950 shares in treasury, therefore the number of ordinary shares in issue less the total number of treasury shares will be 123,699,050 and the total number of voting rights in the Company is 123,699,050.

Β 

Β 

For further information please contact:

Β 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

FTI Consulting

+44 20 7831 3113

Edward Bridges / Emily Hartman

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

Β 

Β 

Β 

About Oakley Capital Investments Limited

Β 

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCIL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P. and, over time, through co-investment opportunities.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
POSFSAFMMFDSELE
Date   Source Headline
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.